Abstract

This study aimed to find a potential biomarker that can be used to diagnose prediabetic condition by comparing the salivary bacterial microbiomes between Thai dental patients with normoglycemia (NG) and those with potential prediabetes (PPG) conditions. Thirty-three subjects were randomly recruited. Demographic data were collected along with oral examination and unstimulated salivary collections. The salivary bacterial microbiomes were identified by high-throughput sequencing on the V3–V4 region of the bacterial 16S rRNA gene. Microbiomes in this study were composed of 12 phyla, 19 classes, 29 orders, 56 families, 81 genera, and 184 species. To check the validity of the selection criterion for prediabetes, we adopted two separate criteria to divide samples into PPG and NG groups using glycated hemoglobin A1c (HbA1c) or fasting plasma glucose (FPG) levels. Using the HbA1c level resulted in the significant reduction of Alloprevotella, Neisseria, Rothia, and Streptococcus abundances in PPG compared with those in NG (p-value < 0.05). On the other hand, the abundance of Absconditabacteriales was significantly reduced whereas Leptotrichia, Stomatobaculum, and Ruminococcaceae increased in the PPG group when the samples were classified by the FPG level (p-value < 0.05). It is implied that the group classifying criterion should be carefully concerned when investigating relative abundances between groups. However, regardless of the criteria, Rothia is significantly dominant in the NG groups, suggesting that Rothia might be a potential prediabetic biomarker. Due to the small sample size of this study, further investigation with a larger sample size is necessary to ensure that Rothia can be a potential biomarker for prediabetes in Thai people.

Highlights

  • The prevalence of type 2 diabetes mellitus (T2DM) is increasing globally [1,2]

  • We study the diversity of the saliva bacterial microbiome in Thai dental patients using 16S rRNA amplification sequencing

  • It is noteworthy that the participants who were classified as PPGFPG were not always PPGHbA1c and vice versa

Read more

Summary

Introduction

The prevalence of type 2 diabetes mellitus (T2DM) is increasing globally [1,2]. In2019, the prevalence of diabetes mellitus (DM) in adults aged 20–79 years old was 9.3%or 463 million people worldwide. The prevalence of type 2 diabetes mellitus (T2DM) is increasing globally [1,2]. In. 2019, the prevalence of diabetes mellitus (DM) in adults aged 20–79 years old was 9.3%. It is predicted to rise to 10.2% or 578 million in 2030 [1]. Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) conditions signify a risk of future development of T2DM [3,4]. The incidence of T2DM progression five years after diagnosis of IGT and IFG was estimated to be 26% and 50%, respectively [3].

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call